Goldman Sachs’s Ortho Clinical Diagnostics Holdings OCDX Stock Holding History
Bought
Maintained
Sold
Other funds holding OCDX
Goldman Sachs's OCDX Position: Q2 2022 in Review
Goldman Sachs sold out of Ortho Clinical Diagnostics Holdings (OCDX) in Q2 2022, closing a stake of 2,191,433 shares — an estimated $40.9M sold.
Goldman Sachs first reported a position in OCDX in Q1 2021 and held it in 5 quarters. The position peaked at $40.9M in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.
- Goldman Sachs reported no remaining Ortho Clinical Diagnostics Holdings position as of Q2 2022 after selling out during the quarter.
- Goldman Sachs sold 2,191,433 Ortho Clinical Diagnostics Holdings shares in Q2 2022, an estimated $40.9M.
- Goldman Sachs first reported a position in Ortho Clinical Diagnostics Holdings in Q1 2021 and held it in 5 quarters.
- Goldman Sachs's Ortho Clinical Diagnostics Holdings position peaked at $40.9M in Q1 2022.
- 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings as of Q2 2022.
Based on Goldman Sachs's 13F filing for Q2 2022, filed 15 Aug 2022.